June 18, 2020 at 8:37 am

MISSD in the News

Prescriptions for drugs marketed as anti-anxiety, anti-insomnia and anti-depression treatments has increased since the COVID19 epidemic began. People who are experiencing normal stress in response to the COVID19 epidemic and decide to start taking these drugs should ask their doctors to discuss risks vs. possible benefits and be aware of signs of akathisia.

MISSD has long publicized that “caregivers and patients should pay close attention to any sudden changes in mood, behaviors, thoughts and feelings when an antidepressant medicine is started or when the dosage is changed.”

Read the full article at https://www.ktva.com/story/42130648/fda-adds-zoloft-to-drug-shortage-list-as-35-of-americans-reporting-anxiety-depression